drugset / Trial / NCT07015268
A Clinical Study of KLH-2109 in Patients With Endometriosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To verify the non-inferiority of KLH-2109 to leuprorelin acetate in a double-blind manner in terms of efficacy in endometriosis patients with pelvic pain.
Timeline
- Start
- 2025-06-09
- Primary completion
- 2027-11
- Completion
- 2027-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KLH-2109 | Unknown | — | Oral |
| Comparator | Leuprolide | Other / unclassified | — | Subcutaneous |